Leiomyomatosis peritonealis disseminata treated with a gonadotropin-releasing hormone agonist. A case report.
To our knowledge, this is the first report of documented growth regression of leiomyomatosis peritonei while the patient was receiving a gonadotropin-releasing hormone agonist. This further documents the role of gonadal steroids in the growth of this tumor.
Hales
H A
HA
Department of Obstetrics and Gynecology, University of Utah Medical Center, Salt Lake City 84132.
Peterson
C M
CM
Jones
K P
KP
Quinn
J D
JD
D000328:Adult; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000502:physiology; D006801:Humans; D007889:Leiomyoma / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D016729:Leuprolide / Q000627:therapeutic use*; D009378:Neoplasms, Multiple Primary; D010534:Peritoneal Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery
D007987:Gonadotropin-Releasing Hormone; D016729:Leuprolide